🔍 Predicting treatment response in breast cancer is crucial for personalized care, but it remains a major challenge. In this context, we have developed a state-of-the-art radiomic tool to predict pathologic complete response (pCR) to neoadjuvant chemotherapy in breast cancer. By leveraging advanced imaging techniques such as MRI and 18F-FDG-PET, our solution improves the ability to predict treatment responses, optimize treatment plans, and improve patient outcomes. 💻 Integrated into QP-Breast®, this tool helps oncologists make more informed and personalized decisions for aggressive cancer subtypes, significantly improving accuracy in breast cancer care. Learn how this technology can make a difference: https://lnkd.in/dKGKvPqB #BreastCancer #AIinHealthcare #Radiomics #PrecisionMedicine #MedicalImaging
"𝘛𝘩𝘦 𝘱𝘭𝘢𝘯 𝘵𝘰 𝘳𝘦𝘴𝘱𝘰𝘯𝘴𝘪𝘣𝘭𝘺 𝘩𝘢𝘳𝘯𝘦𝘴𝘴 𝘵𝘩𝘦 𝘕𝘏𝘚'𝘴 𝘶𝘯𝘱𝘢𝘳𝘢𝘭𝘭𝘦𝘭𝘦𝘥 𝘩𝘦𝘢𝘭𝘵𝘩 𝘥𝘢𝘵𝘢 𝘳𝘦𝘱𝘰𝘴𝘪𝘵𝘰𝘳𝘺, 𝘸𝘩𝘪𝘭𝘦 𝘦𝘯𝘴𝘶𝘳𝘪𝘯𝘨 𝘴𝘵𝘳𝘪𝘤𝘵 𝘤𝘰𝘯𝘵𝘳𝘰𝘭 𝘢𝘯𝘥 𝘱𝘳𝘪𝘷𝘢𝘤𝘺 𝘴𝘢𝘧𝘦𝘨𝘶𝘢𝘳𝘥𝘴, 𝘳𝘦𝘱𝘳𝘦𝘴𝘦𝘯𝘵𝘴 𝘢 𝘵𝘳𝘢𝘯𝘴𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘷𝘦 𝘰𝘱𝘱𝘰𝘳𝘵𝘶𝘯𝘪𝘵𝘺 𝘵𝘰 𝘢𝘥𝘷𝘢𝘯𝘤𝘦 𝘥𝘪𝘢𝘨𝘯𝘰𝘴𝘵𝘪𝘤𝘴, 𝘵𝘳𝘦𝘢𝘵𝘮𝘦𝘯𝘵 𝘱𝘭𝘢𝘯𝘯𝘪𝘯𝘨, 𝘢𝘯𝘥 𝘤𝘩𝘳𝘰𝘯𝘪𝘤 𝘥𝘪𝘴𝘦𝘢𝘴𝘦 𝘮𝘢𝘯𝘢𝘨𝘦𝘮𝘦𝘯𝘵,". Our CEO and Co-Founder, Dr. Ángel Alberich-Bayarri together with the #medicalimaging community, shares his views on the UK government's 26-page AI strategy in this article published on AuntMinnieEurope.com. Read the full piece here to find out why this is a bold step towards the future of hashtag#healthcare innovation in the UK https://lnkd.in/dWSTPUcZ What are your thoughts on this strategy?👇
The last quarter of 2024 marked impressive milestones for us, and we have compiled them for you to read in our quarterly newsletter. 🔔 Stay tuned on the latest developments in AI, medical imaging, and healthcare innovation - subscribe to our newsletter for first-hand updates from Quibim! https://lnkd.in/dj9ybMpf #AIinHealth #MedicalImaging #Q4Results #HealthInnovation
🌟 Kicking off the 2025 events calendar, we are live from Barcelona at the "Triángulo Radiológico 2025". Some members of the hashtag#QuibimTeam participated in different talks: ▪️ Javier Pizcueta Pastor in ‘𝘗𝘦𝘤𝘩𝘢 𝘒𝘶𝘤𝘩𝘢 2: 𝘔𝘰𝘴𝘵 𝘥𝘪𝘴𝘳𝘶𝘱𝘵𝘪𝘷𝘦 𝘢𝘯𝘥 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘷𝘦 𝘱𝘳𝘰𝘱𝘰𝘴𝘢𝘭 𝘪𝘯 𝘈𝘐’. ▪️ Fuensanta Bellvís Bataller, together with Laura Oleaga Zufiria, presented '𝘐𝘮𝘢𝘨𝘦 𝘊𝘰𝘳𝘦𝘭𝘢𝘣’. What a great opportunity to connect with colleagues and discuss the latest innovations in radiology and medical imaging! #TriangleRadiology2025 #MedicalImaging #AIinHealthcare #HealthInnovation
#Radiomics is transforming healthcare, from boosting clinical study success rates to propelling more innovative technologies and elevating patient care. Did you miss our radiomics infographic? If you haven’t seen it yet or want a refresher, here’s your chance! We collaborated with Heber Longás Crespo, a leading infographic specialist, to break down the science behind radiomics and showcase its transformative potential. You can navegate and download the infographics here https://lnkd.in/dK2mqDBs 💬 What’s your take on the impact of radiomics in healthcare? Let us know in the comments—your insights are invaluable! #Innovation #Healthcare #Radiomics
By extracting more than 5000 #radiomic and #deepfeatures from thousands of CT scans, we demonstrate that models developed from one dataset can be effectively applied to another, highlighting their generalizability. AI-based imaging tools are transforming the prediction of immunotherapy outcomes in patients with advanced NSCLC (Non-Small Cell Lung Cancer). Our findings highlight the potential of radiomics to make accurate, non-invasive predictions, advancing personalized cancer care. Read the full case study here: bit.ly/3W4s3B4 #NSCLC #Immunotherapy #PersonalizedCancerCare
🗓️ Wrapping up 2024 with December’s top highlights! 1️⃣ At #RSNA2024, we showcased how QP-Prostate® is redefining precision health and accelerating prostate cancer diagnosis. Watch our team interviews here 👇 2️⃣ Our latest blog post dives into the powerful role that medical imaging and RWE are playing in cancer management. Written by our Medical Advisor, Almudena Fuster Matanzo. 3️⃣ How can we unlock the hidden potential of medical images to transform diagnostics and clinical research? Watch our latest video to find out! 4️⃣ Our November 18th event brought together experts to explore how AI is revolutionizing prostate cancer care—relive the insights in our recap! 💌 Subscribe to our LinkedIn newsletter and stay updated as we prepare for an exciting 2025 full of innovation!
🎉 As we welcome 2025, we are filled with hope and gratitude for the incredible journey that is about to come. This year is about connection, innovation and the human spirit that drives us forward. We wish our incredible medical community another year of groundbreaking discoveries. Together, we will continue to push the boundaries of what is possible. 💙 #HappyNewYear #2025
This year, we’ve been part of incredible innovations, achieved significant milestones, and made steps that we’re truly proud of. 🚀 Sharing knowledge, ideas, and support has been the driving force behind our success. As we reflect on 2024, we want to express our heartfelt gratitude for your encouragement, collaboration, and trust in us. 💡✨ Together, we’ve turned challenges into opportunities and dreams into achievements. Let’s keep shaping the future together! #2024 #companyaccomplishments #AIInHealthcare #Quibim
Last year we collaborated with top infographics specialists to simplify the complex science of #radiomics and make its transformative potential available to everyone from researchers to patients. Radiomics is about ensuring accuracy at every step, from imaging and processing to linking data to clinical outcomes, driving impact across industries: improving the success rate of clinical studies in life sciences and research, enabling smarter and more innovative machines for OEMs, and enabling clinicians to make better-informed decisions for patient care. Thanks to radiomics, we are shaping the future of medicine and science. Join our community. Visit our website to experience this innovative tool, available in English, Spanish, and French, and see how radiomics is reshaping the future of healthcare, one breakthrough at a time 👉 https://lnkd.in/dPHBEesM
